StockData
Kodiak Sciences Inc. logo

Kodiak Sciences Inc. (KOD) income statement

KODNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$97.17−0.73 (-0.75%)

Close on Nov 20, 2026Market cap $6.11BP/E –Yield –

See a number that looks wrong?